Pristimerin, a Triterpenoid, Inhibits Tumor Angiogenesis by Targeting VEGFR2 Activation
Xianmin Mu(Jinan Central Hospital), Luyong Zhang(Guangdong Pharmaceutical University)
Cited by 51
Related Papers
Oncometabolite succinate promotes angiogenesis by upregulating VEGF expression through GPR91-mediated STAT3 and ERK activation
|Oncotarget|2017|118
Osteopontin promotes hepatocellular carcinoma progression through inducing JAK2/STAT3/NOX1-mediated ROS production
|Cell Death and Disease|2022|62
Mitochondria-dependent apoptosis in triptolide-induced hepatotoxicity is associated with the Drp1 activation
|Toxicology Mechanisms and Methods|2019|53